Topic

Aetna (CVS Health)

A collection of 1143 issues

How to Get Synagis (Palivizumab) Covered by Aetna in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Synagis Approved by Aetna in Washington Aetna requires prior authorization for Synagis (palivizumab) and prioritizes Beyfortus as first-line therapy. To get coverage in Washington: (1) Submit Aetna's Synagis precertification form with clinical documentation proving high-risk criteria, (2) demonstrate why Beyfortus is contraindicated or inappropriate, and
6 min read

How to Get Arcalyst (rilonacept) Covered by Aetna in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Arcalyst Covered by Aetna in New Jersey Fastest path to approval: Submit prior authorization through Availity provider portal with complete documentation including specialist consultation, prior therapy failures, and elevated inflammatory markers. Standard decisions take 45 business days; expedited reviews complete within 72 hours for urgent cases. If
6 min read

How to Get Darzalex / Darzalex Faspro (daratumumab) Covered by Aetna in Michigan: Prior Authorization Guide and Appeals Process

Answer Box: Getting Darzalex / Darzalex Faspro Covered by Aetna in Michigan Aetna requires prior authorization for both Darzalex (IV) and Darzalex Faspro (subcutaneous) in Michigan. Submit your PA request to (866) 752-7021 or fax (888) 267-3277 with complete clinical documentation including diagnosis, prior therapy failures, and treatment plan. If denied,
5 min read

If Tavneos (Avacopan) Isn't Approved by Aetna (CVS Health) in Virginia: Formulary Alternatives & Exception Paths

Answer Box: Your Path Forward If Aetna (CVS Health) denies Tavneos (avacopan) for ANCA-associated vasculitis in Virginia, you have two main options: try formulary alternatives with step therapy or request a medical exception. First step today: Contact your rheumatologist or nephrologist to discuss rituximab or cyclophosphamide as alternatives while simultaneously
6 min read